| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 20 | 2024 | 1123 | 2.680 |
Why?
|
| Cardiology | 6 | 2026 | 510 | 1.460 |
Why?
|
| Heart Defects, Congenital | 17 | 2024 | 1878 | 1.090 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 5 | 2026 | 78 | 1.090 |
Why?
|
| Heart Diseases | 3 | 2026 | 501 | 0.920 |
Why?
|
| Coronary Aneurysm | 3 | 2026 | 34 | 0.900 |
Why?
|
| Echocardiography, Doppler | 6 | 2024 | 159 | 0.860 |
Why?
|
| Societies, Medical | 3 | 2021 | 791 | 0.850 |
Why?
|
| Fetal Heart | 6 | 2025 | 134 | 0.730 |
Why?
|
| Fetal Diseases | 5 | 2018 | 457 | 0.620 |
Why?
|
| Hypoplastic Left Heart Syndrome | 5 | 2025 | 268 | 0.600 |
Why?
|
| Heart Block | 1 | 2018 | 37 | 0.570 |
Why?
|
| Ventricular Function, Left | 6 | 2021 | 535 | 0.540 |
Why?
|
| Utilization Review | 1 | 2015 | 39 | 0.470 |
Why?
|
| Program Evaluation | 1 | 2017 | 441 | 0.460 |
Why?
|
| Ultrasonography, Prenatal | 10 | 2020 | 994 | 0.440 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 680 | 0.440 |
Why?
|
| Diastole | 1 | 2015 | 178 | 0.430 |
Why?
|
| Clinical Competence | 3 | 2020 | 1045 | 0.430 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 78 | 0.430 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2026 | 131 | 0.420 |
Why?
|
| Heart Ventricles | 8 | 2022 | 757 | 0.410 |
Why?
|
| Coronary Vessels | 1 | 2017 | 523 | 0.400 |
Why?
|
| Pregnancy | 18 | 2026 | 7423 | 0.380 |
Why?
|
| Patient Safety | 2 | 2020 | 440 | 0.360 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2021 | 356 | 0.330 |
Why?
|
| Biomedical Research | 1 | 2015 | 561 | 0.300 |
Why?
|
| Humans | 56 | 2026 | 130403 | 0.280 |
Why?
|
| Internship and Residency | 2 | 2020 | 1211 | 0.280 |
Why?
|
| Pediatrics | 2 | 2017 | 1244 | 0.280 |
Why?
|
| Pediatricians | 3 | 2026 | 75 | 0.270 |
Why?
|
| Child | 21 | 2026 | 26159 | 0.260 |
Why?
|
| Infant, Newborn | 17 | 2025 | 8525 | 0.250 |
Why?
|
| Myocardial Contraction | 2 | 2019 | 241 | 0.240 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2019 | 146 | 0.240 |
Why?
|
| Predictive Value of Tests | 7 | 2026 | 2298 | 0.240 |
Why?
|
| School Nursing | 1 | 2026 | 9 | 0.240 |
Why?
|
| Vein of Galen Malformations | 1 | 2025 | 15 | 0.230 |
Why?
|
| Fetofetal Transfusion | 2 | 2020 | 206 | 0.230 |
Why?
|
| Tetralogy of Fallot | 2 | 2019 | 167 | 0.230 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2026 | 59 | 0.230 |
Why?
|
| Cardiac Catheterization | 2 | 2025 | 623 | 0.230 |
Why?
|
| Atrial Septum | 1 | 2025 | 19 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2025 | 3841 | 0.230 |
Why?
|
| Fetal Therapies | 1 | 2026 | 96 | 0.220 |
Why?
|
| Female | 36 | 2026 | 70343 | 0.220 |
Why?
|
| Coronary Circulation | 1 | 2026 | 187 | 0.220 |
Why?
|
| Retrospective Studies | 20 | 2026 | 17633 | 0.200 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2020 | 245 | 0.200 |
Why?
|
| Resuscitation | 1 | 2026 | 276 | 0.200 |
Why?
|
| United States | 5 | 2024 | 11826 | 0.190 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2025 | 341 | 0.190 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 2098 | 0.190 |
Why?
|
| Spinal Dysraphism | 1 | 2026 | 279 | 0.180 |
Why?
|
| Fetoscopy | 1 | 2026 | 480 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2022 | 153 | 0.170 |
Why?
|
| Echocardiography, Doppler, Color | 3 | 2016 | 110 | 0.160 |
Why?
|
| Education, Distance | 1 | 2020 | 69 | 0.150 |
Why?
|
| Postoperative Complications | 4 | 2016 | 3105 | 0.150 |
Why?
|
| Ventricular Function, Right | 2 | 2021 | 123 | 0.150 |
Why?
|
| Etanercept | 1 | 2019 | 44 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 500 | 0.150 |
Why?
|
| Gestational Age | 7 | 2025 | 1223 | 0.140 |
Why?
|
| Pregnancy Outcome | 3 | 2016 | 620 | 0.140 |
Why?
|
| Preoperative Care | 1 | 2000 | 356 | 0.140 |
Why?
|
| Curriculum | 3 | 2020 | 784 | 0.140 |
Why?
|
| Infant | 15 | 2026 | 13276 | 0.130 |
Why?
|
| Vascular Resistance | 1 | 2018 | 182 | 0.130 |
Why?
|
| Fetus | 3 | 2021 | 582 | 0.130 |
Why?
|
| Antibodies | 1 | 2018 | 317 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 299 | 0.130 |
Why?
|
| Torsion Abnormality | 1 | 2016 | 28 | 0.120 |
Why?
|
| Patient Selection | 1 | 2000 | 719 | 0.120 |
Why?
|
| Fellowships and Scholarships | 2 | 2017 | 323 | 0.120 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2000 | 384 | 0.120 |
Why?
|
| Ventricular Function | 1 | 2016 | 83 | 0.120 |
Why?
|
| Cardiac Output | 1 | 2016 | 152 | 0.120 |
Why?
|
| Male | 22 | 2026 | 64486 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2020 | 6447 | 0.120 |
Why?
|
| Laser Coagulation | 1 | 2016 | 117 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 1 | 2018 | 485 | 0.110 |
Why?
|
| Oxygen | 1 | 2018 | 551 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 363 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 374 | 0.110 |
Why?
|
| Mitral Valve | 1 | 2016 | 246 | 0.110 |
Why?
|
| Hyperoxia | 1 | 2016 | 135 | 0.110 |
Why?
|
| Congresses as Topic | 1 | 2015 | 185 | 0.110 |
Why?
|
| Ebstein Anomaly | 1 | 2014 | 29 | 0.100 |
Why?
|
| Reproducibility of Results | 5 | 2025 | 2923 | 0.100 |
Why?
|
| Hydrops Fetalis | 2 | 2012 | 85 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1292 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2014 | 187 | 0.100 |
Why?
|
| Child, Preschool | 11 | 2026 | 14982 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 130 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 3 | 2016 | 353 | 0.090 |
Why?
|
| Prenatal Diagnosis | 2 | 2020 | 646 | 0.090 |
Why?
|
| Electroencephalography | 1 | 2016 | 855 | 0.090 |
Why?
|
| Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 2012 | 19 | 0.090 |
Why?
|
| Adrenalectomy | 1 | 2012 | 32 | 0.090 |
Why?
|
| Pheochromocytoma | 1 | 2012 | 32 | 0.090 |
Why?
|
| Vascular Neoplasms | 1 | 2012 | 31 | 0.090 |
Why?
|
| Hemodynamics | 4 | 2022 | 802 | 0.090 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 535 | 0.090 |
Why?
|
| Aortic Valve | 2 | 2016 | 456 | 0.090 |
Why?
|
| Cardiomyopathies | 1 | 2016 | 515 | 0.090 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2012 | 67 | 0.080 |
Why?
|
| Risk Factors | 6 | 2026 | 10981 | 0.080 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2012 | 107 | 0.080 |
Why?
|
| Texas | 5 | 2016 | 3614 | 0.080 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2010 | 61 | 0.080 |
Why?
|
| Treatment Outcome | 9 | 2025 | 12852 | 0.080 |
Why?
|
| Infant, Low Birth Weight | 1 | 2010 | 169 | 0.080 |
Why?
|
| Umbilical Arteries | 2 | 2020 | 99 | 0.070 |
Why?
|
| Bioprosthesis | 1 | 2010 | 110 | 0.070 |
Why?
|
| Time Factors | 3 | 2026 | 6183 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 2010 | 208 | 0.070 |
Why?
|
| Pericardium | 1 | 1989 | 104 | 0.070 |
Why?
|
| Adolescent | 11 | 2016 | 20731 | 0.070 |
Why?
|
| Stroke Volume | 4 | 2016 | 529 | 0.070 |
Why?
|
| Heart Valve Prosthesis | 1 | 2010 | 302 | 0.060 |
Why?
|
| Drug Resistance | 2 | 2019 | 247 | 0.060 |
Why?
|
| Return to Sport | 1 | 2026 | 5 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2026 | 3692 | 0.060 |
Why?
|
| Syncope | 1 | 2026 | 53 | 0.060 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2010 | 428 | 0.060 |
Why?
|
| Albumins | 1 | 2005 | 88 | 0.060 |
Why?
|
| Chest Pain | 1 | 2026 | 124 | 0.060 |
Why?
|
| Pericardial Effusion | 1 | 2005 | 72 | 0.060 |
Why?
|
| Infant, Premature | 1 | 2010 | 851 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1487 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2005 | 68 | 0.050 |
Why?
|
| Stents | 1 | 2010 | 781 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2026 | 197 | 0.050 |
Why?
|
| Myocarditis | 1 | 2026 | 132 | 0.050 |
Why?
|
| Endophthalmitis | 1 | 2004 | 49 | 0.050 |
Why?
|
| Family | 1 | 2007 | 579 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2026 | 204 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2007 | 493 | 0.050 |
Why?
|
| Transposition of Great Vessels | 1 | 2004 | 124 | 0.050 |
Why?
|
| Hemangioma | 1 | 2004 | 89 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2018 | 1452 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2004 | 128 | 0.050 |
Why?
|
| Acute Disease | 2 | 2019 | 1150 | 0.050 |
Why?
|
| Meningomyelocele | 1 | 2026 | 275 | 0.050 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2004 | 149 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2026 | 557 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2007 | 700 | 0.040 |
Why?
|
| Contrast Media | 1 | 2005 | 492 | 0.040 |
Why?
|
| Prognosis | 2 | 2026 | 4901 | 0.040 |
Why?
|
| Adult | 9 | 2026 | 31125 | 0.040 |
Why?
|
| Heart Atria | 2 | 2016 | 333 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 890 | 0.040 |
Why?
|
| Aorta | 1 | 2004 | 522 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2022 | 296 | 0.040 |
Why?
|
| Pulmonary Artery | 2 | 2019 | 437 | 0.040 |
Why?
|
| Hospital Charges | 1 | 2000 | 68 | 0.040 |
Why?
|
| Occupational Health | 1 | 2020 | 46 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2000 | 158 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2020 | 185 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2012 | 440 | 0.040 |
Why?
|
| Infection Control | 1 | 2020 | 160 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2000 | 783 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2000 | 938 | 0.040 |
Why?
|
| Palliative Care | 1 | 2022 | 438 | 0.040 |
Why?
|
| Pulsatile Flow | 1 | 2018 | 110 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2019 | 266 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2018 | 80 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 693 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2016 | 5204 | 0.030 |
Why?
|
| Drug Therapy, Combination | 2 | 2019 | 1163 | 0.030 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1998 | 110 | 0.030 |
Why?
|
| Aortic Coarctation | 1 | 1998 | 96 | 0.030 |
Why?
|
| Torsion, Mechanical | 1 | 2016 | 6 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1997 | 145 | 0.030 |
Why?
|
| Survival Rate | 2 | 2016 | 2134 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2018 | 759 | 0.030 |
Why?
|
| Time | 1 | 2016 | 93 | 0.030 |
Why?
|
| Perinatal Mortality | 1 | 2016 | 43 | 0.030 |
Why?
|
| Hand Deformities, Congenital | 1 | 1997 | 95 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2004 | 898 | 0.030 |
Why?
|
| Twins | 1 | 2016 | 70 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2016 | 47 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2016 | 31 | 0.030 |
Why?
|
| Reference Standards | 1 | 2016 | 230 | 0.030 |
Why?
|
| Systole | 1 | 2016 | 193 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2004 | 1151 | 0.030 |
Why?
|
| Craniofacial Abnormalities | 1 | 1997 | 252 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 2111 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 179 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1625 | 0.030 |
Why?
|
| Radiography | 2 | 2004 | 750 | 0.030 |
Why?
|
| Length of Stay | 1 | 2000 | 1393 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 679 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 1997 | 653 | 0.030 |
Why?
|
| Renal Dialysis | 1 | 2021 | 946 | 0.030 |
Why?
|
| ROC Curve | 1 | 2016 | 610 | 0.030 |
Why?
|
| Pyrazinamide | 1 | 1993 | 10 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2012 | 967 | 0.030 |
Why?
|
| Ethambutol | 1 | 1993 | 6 | 0.030 |
Why?
|
| Streptomycin | 1 | 1993 | 12 | 0.030 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2013 | 52 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2004 | 135 | 0.020 |
Why?
|
| Learning Curve | 1 | 2013 | 54 | 0.020 |
Why?
|
| Isoniazid | 1 | 1993 | 65 | 0.020 |
Why?
|
| Rifampin | 1 | 1993 | 122 | 0.020 |
Why?
|
| Age Factors | 1 | 2019 | 2835 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1154 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2013 | 203 | 0.020 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 1993 | 142 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2014 | 3030 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1997 | 970 | 0.020 |
Why?
|
| Pulmonary Valve Stenosis | 1 | 1991 | 35 | 0.020 |
Why?
|
| Heart Aneurysm | 1 | 1991 | 30 | 0.020 |
Why?
|
| Myocardium | 1 | 2016 | 858 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3805 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 228 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2010 | 87 | 0.020 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1991 | 358 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 420 | 0.020 |
Why?
|
| Blood Flow Velocity | 2 | 2005 | 418 | 0.020 |
Why?
|
| Aging | 1 | 2016 | 1251 | 0.020 |
Why?
|
| Abortion, Eugenic | 1 | 2008 | 11 | 0.020 |
Why?
|
| Pericardiocentesis | 1 | 2007 | 17 | 0.020 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2008 | 97 | 0.020 |
Why?
|
| Chest Tubes | 1 | 2007 | 38 | 0.020 |
Why?
|
| Hernia, Umbilical | 1 | 2008 | 45 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2007 | 50 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2010 | 613 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2016 | 5084 | 0.020 |
Why?
|
| Brain | 1 | 2018 | 3188 | 0.020 |
Why?
|
| Swine | 1 | 2010 | 1183 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2007 | 142 | 0.010 |
Why?
|
| Reoperation | 2 | 2004 | 830 | 0.010 |
Why?
|
| Microspheres | 1 | 2005 | 67 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 238 | 0.010 |
Why?
|
| Fetal Death | 1 | 2005 | 118 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2004 | 26 | 0.010 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2004 | 19 | 0.010 |
Why?
|
| Central Nervous System Venous Angioma | 1 | 2004 | 2 | 0.010 |
Why?
|
| Observer Variation | 1 | 2005 | 311 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2007 | 285 | 0.010 |
Why?
|
| Tracheal Neoplasms | 1 | 2004 | 21 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 175 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 239 | 0.010 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2007 | 320 | 0.010 |
Why?
|
| Surveys and Questionnaires | 2 | 2007 | 4015 | 0.010 |
Why?
|
| Pulmonary Valve | 1 | 2004 | 87 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2007 | 553 | 0.010 |
Why?
|
| Abscess | 1 | 2004 | 136 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 167 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2005 | 575 | 0.010 |
Why?
|
| Aortic Diseases | 1 | 2004 | 188 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 9974 | 0.010 |
Why?
|
| Syndrome | 1 | 2004 | 1160 | 0.010 |
Why?
|
| Maternal Age | 1 | 2001 | 133 | 0.010 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2004 | 283 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 1893 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 1998 | 125 | 0.010 |
Why?
|
| Chromosome Banding | 1 | 1997 | 135 | 0.010 |
Why?
|
| Karyotyping | 1 | 1997 | 312 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1996 | 65 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 227 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 1395 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1993 | 1610 | 0.000 |
Why?
|
| Animals | 1 | 2010 | 33852 | 0.000 |
Why?
|
| Phenotype | 1 | 1997 | 4475 | 0.000 |
Why?
|
| Tuberculosis | 1 | 1993 | 553 | 0.000 |
Why?
|
| Middle Aged | 2 | 1996 | 28395 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1993 | 6773 | 0.000 |
Why?
|
| Aged | 1 | 1993 | 20899 | 0.000 |
Why?
|